Therapeutic Options for Adult T-Cell Leukemia/Lymphoma

Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study

(2012) J. Kanda et al.   BLOOD

Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience

(2012) H. Itonaga et al.   BLOOD

Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study

(2012) Takashi Ishida et al.   JOURNAL OF CLINICAL ONCOLOGY

Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

(2012) Bertrand Coiffier et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

(2011) R. L. Piekarz et al.   BLOOD

Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL)

(2011) Atae Utsunomiya et al.   Retrovirology

Targeting HTLV-I latency in Adult T-cell Leukemia/Lymphoma

(2011) Juan C Ramos et al.   Retrovirology

Arsenic trioxyde in the treatment of HTLV1 associated ATLL

(2011) Felipe Suarez et al.   Retrovirology

Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level

(2011) Naokuni Uike et al.   Retrovirology

A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients

(2011) Ivan C Moura et al.   Retrovirology

Controversies in Targeted Therapy of Adult T Cell Leukemia/Lymphoma: ON Target or OFF Target Effects?

(2011) Rihab Nasr et al.   Viruses-Basel

Long-term study of indolent adult T-cell leukemia-lymphoma

(2010) Y. Takasaki et al.   BLOOD

Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study

(2010) M. Hishizawa et al.   BLOOD

Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors

(2010) P. V. Afonso et al.   BLOOD

Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic Subtypes

(2010) Ali Bazarbachi et al.   JOURNAL OF CLINICAL ONCOLOGY

Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

(2010) Sean J. Whittaker et al.   JOURNAL OF CLINICAL ONCOLOGY

Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia

(2010) Hiba El Hajj et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)

(2009) G. Kchour et al.   BLOOD

Susceptibility of human T-cell leukemia virus type I-infected cells to humanized anti-CD30 monoclonal antibodies in vitro and in vivo

(2009) Naoyoshi Maeda et al.   CANCER SCIENCE

Phase II Study of Alemtuzumab in Combination With Pentostatin in Patients With T-Cell Neoplasms

(2009) Farhad Ravandi et al.   JOURNAL OF CLINICAL ONCOLOGY